- Investing Ideas
- Chinese Pharmaceuticals & Biotech Spotless Management
Chinese Pharmaceuticals & Biotech Spotless Management
Results
2
0 new
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
2 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥38.3b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥85.50
7D
0.9%
1Y
-8.6%
Xiamen Amoytop Biotech
Market Cap: CN¥22.8b
Xiamen Amoytop Biotech Co., Ltd. se dedica a la investigación, desarrollo, producción y venta de fármacos de proteínas recombinantes en China.
688278
CN¥53.79
7D
-5.6%
1Y
-23.5%